Filters: Author is Alexander, G. C. [Clear All Filters]
Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016. JAMA Intern Med. 2018;178:1451-1457. Abstract
.
Reducing branded prescription drug prices: A review of policy options. Pharmacotherapy. 2017. Abstract
.
Branded prescription drug spending: a framework to evaluate policy options. J Pharm Policy Pract. 2017;10:31. Abstract
.
Effect of a "pill mill" law on opioid prescribing and utilization: The case of Texas. Drug Alcohol Depend. 2016;159:190-7. Abstract
.
.
Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. JAMA Intern Med. 2015;175:1642-9. Abstract
.
Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs. Health Aff (Millwood). 2015;34:467-76. Abstract
.